HK1045506A1 - Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods - Google Patents

Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods

Info

Publication number
HK1045506A1
HK1045506A1 HK02106888A HK02106888A HK1045506A1 HK 1045506 A1 HK1045506 A1 HK 1045506A1 HK 02106888 A HK02106888 A HK 02106888A HK 02106888 A HK02106888 A HK 02106888A HK 1045506 A1 HK1045506 A1 HK 1045506A1
Authority
HK
Hong Kong
Prior art keywords
iüdihydropyridines
oxathiepino
methods
related compositions
compositions
Prior art date
Application number
HK02106888A
Other versions
HK1045506B (en
Inventor
John H Dodd
James R Henry
Kenneth C Rupert
James L Bullington
Daniel A Hall
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HK1045506A1 publication Critical patent/HK1045506A1/en
Publication of HK1045506B publication Critical patent/HK1045506B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK02106888.0A 1999-07-12 2002-09-20 Oxathiepino 6,5- i b /i ]dihydropyridines, and related compositions and methods HK1045506B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14335499P 1999-07-12 1999-07-12
PCT/US2000/017310 WO2001004124A1 (en) 1999-07-12 2000-06-23 OXATHIEPINO[6,5-b]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS

Publications (2)

Publication Number Publication Date
HK1045506A1 true HK1045506A1 (en) 2002-11-29
HK1045506B HK1045506B (en) 2006-02-03

Family

ID=22503704

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106888.0A HK1045506B (en) 1999-07-12 2002-09-20 Oxathiepino 6,5- i b /i ]dihydropyridines, and related compositions and methods

Country Status (22)

Country Link
US (1) US6476022B1 (en)
EP (1) EP1200446B1 (en)
JP (1) JP2003504373A (en)
KR (1) KR20020012308A (en)
CN (1) CN1188416C (en)
AR (1) AR030396A1 (en)
AT (1) ATE302206T1 (en)
AU (1) AU779498B2 (en)
BR (1) BR0012386A (en)
CA (1) CA2379199A1 (en)
CZ (1) CZ2002126A3 (en)
DE (1) DE60022056T2 (en)
DK (1) DK1200446T3 (en)
ES (1) ES2246248T3 (en)
HK (1) HK1045506B (en)
HU (1) HUP0202265A3 (en)
IL (2) IL147540A0 (en)
MX (1) MXPA02000436A (en)
PL (1) PL352760A1 (en)
RU (1) RU2257388C2 (en)
TW (1) TWI256394B (en)
WO (1) WO2001004124A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200503733A (en) * 2003-03-28 2005-02-01 Nissan Chemical Ind Ltd T-shaped channel blockers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA429975A (en) 1945-09-11 F. D'alelio Gaetano Triazine derivative
US4285955A (en) 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
US4483985A (en) 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
NZ201395A (en) 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58201764A (en) 1982-05-17 1983-11-24 Maruko Seiyaku Kk Dihydropyridine derivative
JPS6139760A (en) 1984-07-31 1986-02-25 Toshiba Electric Equip Corp Interphone device for multiple dwelliing house
JPS62253161A (en) 1986-01-29 1987-11-04 Fuji Photo Film Co Ltd Color image forming method
US4777167A (en) * 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4845225A (en) 1986-04-09 1989-07-04 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno [3,2-b] pyridines
US4879384A (en) 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) * 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
DE19532320A1 (en) 1995-09-01 1997-03-06 Bayer Ag Process for the preparation of optically active ortho-substituted 4-aryl-dihydropyridines
BR0012215A (en) * 1999-06-14 2002-07-02 Ortho Mcneil Pharm Inc Dithiepin [6,5-b] pyridines and related compositions and methods

Also Published As

Publication number Publication date
HUP0202265A3 (en) 2004-12-28
IL147540A (en) 2006-12-10
PL352760A1 (en) 2003-09-08
US6476022B1 (en) 2002-11-05
MXPA02000436A (en) 2002-10-11
CA2379199A1 (en) 2001-01-18
HUP0202265A2 (en) 2002-10-28
WO2001004124A1 (en) 2001-01-18
CZ2002126A3 (en) 2003-04-16
AR030396A1 (en) 2003-08-20
TWI256394B (en) 2006-06-11
AU779498B2 (en) 2005-01-27
IL147540A0 (en) 2002-08-14
EP1200446A1 (en) 2002-05-02
BR0012386A (en) 2002-05-28
CN1188416C (en) 2005-02-09
ATE302206T1 (en) 2005-09-15
DE60022056T2 (en) 2006-06-08
RU2257388C2 (en) 2005-07-27
AU6605000A (en) 2001-01-30
EP1200446B1 (en) 2005-08-17
ES2246248T3 (en) 2006-02-16
DK1200446T3 (en) 2005-10-24
JP2003504373A (en) 2003-02-04
HK1045506B (en) 2006-02-03
DE60022056D1 (en) 2005-09-22
KR20020012308A (en) 2002-02-15
CN1372563A (en) 2002-10-02

Similar Documents

Publication Publication Date Title
EP1176948A4 (en) Anti-nausea compositions and methods
IL190220A0 (en) Novel composition and use
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
HUP0103562A3 (en) Novel compositions and use
EP1056456A4 (en) R-lansoprazole compositions and methods
EP1056457A4 (en) S-lansoprazole compositions and methods
EP1210084A4 (en) Pyridomorphinans, thienomoprhinans and use thereof
EP1113815A4 (en) Immunogenic compositions and uses thereof
EP1073333A4 (en) S-rabeprazole compositions and methods
PL353214A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
EG22491A (en) Rest-breaking composition and use thereof
GB9922135D0 (en) Compositions and uses
HK1045506A1 (en) Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods
IL162223A0 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof
EP1073332A4 (en) R-rabeprazole compositions and methods
IL146812A0 (en) Streptogramin derivatives, production thereof and compositions containing the same
IL149607A0 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3 benzazocines and the use thereof as medicaments
GB9911606D0 (en) Composition and use
HRP20020971A2 (en) 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors
GB9928549D0 (en) Compositions and methods
GB9916503D0 (en) Compositions and methods
GB9902051D0 (en) Compositions and methods
GB9916506D0 (en) Compositions and methods
GB9921747D0 (en) Compositions and methods
GB9914167D0 (en) Compositions and uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090623